Alpha-2A adrenergic receptor agonist
This page covers all Alpha-2A adrenergic receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-2A adrenergic receptor.
Targets
Marketed (3)
- Guanfacine/Tenex · Research Foundation for Mental Hygiene, Inc. · Psychiatry / Neurology
Guanfacine is an alpha-2A adrenergic receptor agonist that reduces norepinephrine release in the brain, decreasing sympathetic nervous system activity. - Guanfacine (GUA) · Children's Hospital Medical Center, Cincinnati · Neurology / Psychiatry
Guanfacine is an alpha-2A adrenergic receptor agonist that reduces norepinephrine release in the brain, decreasing sympathetic nervous system activity. - Guanfacine (sustained release) · Neurology Group of Bergen County, P.A. · Neurology / Psychiatry
Guanfacine is an alpha-2A adrenergic receptor agonist that reduces norepinephrine activity in the prefrontal cortex to improve attention and impulse control.
Phase 3 pipeline (1)
- SPD503 (Guanfacine HCl) · Shire · Neurology / Psychiatry
Guanfacine is an alpha-2A adrenergic receptor agonist that reduces norepinephrine activity in the prefrontal cortex to improve attention and impulse control.